Table 3.

Comparative study prevalence of skin diseases in community-based studies.

References Our study Fung and Lo5
1996–1997
Hogewoning et al.11
2004–2007
Chen et al.6
2007
Yamamah et al.10
2008–2009
Komba and Mgonda9
2010
El-Khateeb et al.8
2011–2012
Uludağ et al.7
2016
2007 2005 2007
City/countryThailandHong KongGhanaGabonRwandaMagong, Penghu/TaiwanSouth Sinai/EgyptDar es Salaam/TanzaniaDamietta/EgyptTurkey
Numbern = 556n = 559n = 1,394n = 454n= 2,528n = 3,237n = 2,194n = 420n = 6,162n = 1,386
Mean age (year)
(range)
9.3
(5–14)

(6–12.5)

(4–20)

(4–20)

(4–16)

(6–11)

(≤18)
11.4
(6–19)

(6–12)
7.31 ± 1.24
(5–14)
Rank 1stPIH
58.3%
Atopic eczema/eczema
7.6%
Tinea capitis
8.7%
Tinea capitis
23.1%
Tinea capitis
20.6%
Acne
17.3%
Pediculosis
37.6%
Acne
36.4%
Benign neoplasm
87%
Acquired melanocytic nevus
70.2%
2ndNevus/mole
40.1%
Nevus
4.8%
Scar
7%
Papular urticaria
7.5%
Prurigo simplex
2.1%
Ephelides
15.24%
Pityriasis alba
18.3%
Dermatophytosis
11.4%
Pigmentary disorder
68.3%
Postinflammatory hypopigmentation
15.4%
3rdInsect bite reaction
28.0%
Cafe au lait
4.5%
Pyoderma
5.8%
Miliaria/heat rash
4.2%
Acne
1.3%
Atopic dermatitis
4.32%
Xerosis
11.8%
Non specific dermatoses
10.7%
Infection
5.6%
Xerosis
6.6%
4thAcanthosis nigricans
20.0%
Acne
1.6%
Miliaria/heat rash
5.2%
Eczema
4%
Pyoderma
1.3%
Verruca vulgaris
2.78%
Seborrhoeic dermatitis
6.7%
Pityriasis vesicolor
8.6%
Adnexal disorders
4.8%
Pityriasis alba
5.5%
5thAcne
13.7%
Mongolian spot
1.1%
Acne
4.7%
Prurigo simplex
3.7%
Eczema
0.8%
Keloid
0.33%
Wart
4.1%
Non specific ulcer
5%
Hypersensitivity diseases
14%
Livedo reticularis
5%
6thPityriasis alba
12.9%
Fungal infection
0.9%
Nevus and Prurigo simplex
3.7%
Other tinea
2.6%
Verrucae
0.4%
Tinea nigra, tinea versicolor, vitiligo
0.09%
Photosensitivity
4%
Pyoderma
4%
Genodermatoses
0.3%
Keratosis pilaris
4.8%
RemarksSchool and community basedSchool-based studySchool-based studySchool-based studyCommunity-based study (campaign field visit)School-based studySchool-based studySchool-based study
References Our study Fung and Lo5
1996–1997
Hogewoning et al.11
2004–2007
Chen et al.6
2007
Yamamah et al.10
2008–2009
Komba and Mgonda9
2010
El-Khateeb et al.8
2011–2012
Uludağ et al.7
2016
2007 2005 2007
City/countryThailandHong KongGhanaGabonRwandaMagong, Penghu/TaiwanSouth Sinai/EgyptDar es Salaam/TanzaniaDamietta/EgyptTurkey
Numbern = 556n = 559n = 1,394n = 454n= 2,528n = 3,237n = 2,194n = 420n = 6,162n = 1,386
Mean age (year)
(range)
9.3
(5–14)

(6–12.5)

(4–20)

(4–20)

(4–16)

(6–11)

(≤18)
11.4
(6–19)

(6–12)
7.31 ± 1.24
(5–14)
Rank 1stPIH
58.3%
Atopic eczema/eczema
7.6%
Tinea capitis
8.7%
Tinea capitis
23.1%
Tinea capitis
20.6%
Acne
17.3%
Pediculosis
37.6%
Acne
36.4%
Benign neoplasm
87%
Acquired melanocytic nevus
70.2%
2ndNevus/mole
40.1%
Nevus
4.8%
Scar
7%
Papular urticaria
7.5%
Prurigo simplex
2.1%
Ephelides
15.24%
Pityriasis alba
18.3%
Dermatophytosis
11.4%
Pigmentary disorder
68.3%
Postinflammatory hypopigmentation
15.4%
3rdInsect bite reaction
28.0%
Cafe au lait
4.5%
Pyoderma
5.8%
Miliaria/heat rash
4.2%
Acne
1.3%
Atopic dermatitis
4.32%
Xerosis
11.8%
Non specific dermatoses
10.7%
Infection
5.6%
Xerosis
6.6%
4thAcanthosis nigricans
20.0%
Acne
1.6%
Miliaria/heat rash
5.2%
Eczema
4%
Pyoderma
1.3%
Verruca vulgaris
2.78%
Seborrhoeic dermatitis
6.7%
Pityriasis vesicolor
8.6%
Adnexal disorders
4.8%
Pityriasis alba
5.5%
5thAcne
13.7%
Mongolian spot
1.1%
Acne
4.7%
Prurigo simplex
3.7%
Eczema
0.8%
Keloid
0.33%
Wart
4.1%
Non specific ulcer
5%
Hypersensitivity diseases
14%
Livedo reticularis
5%
6thPityriasis alba
12.9%
Fungal infection
0.9%
Nevus and Prurigo simplex
3.7%
Other tinea
2.6%
Verrucae
0.4%
Tinea nigra, tinea versicolor, vitiligo
0.09%
Photosensitivity
4%
Pyoderma
4%
Genodermatoses
0.3%
Keratosis pilaris
4.8%
RemarksSchool and community basedSchool-based studySchool-based studySchool-based studyCommunity-based study (campaign field visit)School-based studySchool-based studySchool-based study
Table 3.

Comparative study prevalence of skin diseases in community-based studies.

References Our study Fung and Lo5
1996–1997
Hogewoning et al.11
2004–2007
Chen et al.6
2007
Yamamah et al.10
2008–2009
Komba and Mgonda9
2010
El-Khateeb et al.8
2011–2012
Uludağ et al.7
2016
2007 2005 2007
City/countryThailandHong KongGhanaGabonRwandaMagong, Penghu/TaiwanSouth Sinai/EgyptDar es Salaam/TanzaniaDamietta/EgyptTurkey
Numbern = 556n = 559n = 1,394n = 454n= 2,528n = 3,237n = 2,194n = 420n = 6,162n = 1,386
Mean age (year)
(range)
9.3
(5–14)

(6–12.5)

(4–20)

(4–20)

(4–16)

(6–11)

(≤18)
11.4
(6–19)

(6–12)
7.31 ± 1.24
(5–14)
Rank 1stPIH
58.3%
Atopic eczema/eczema
7.6%
Tinea capitis
8.7%
Tinea capitis
23.1%
Tinea capitis
20.6%
Acne
17.3%
Pediculosis
37.6%
Acne
36.4%
Benign neoplasm
87%
Acquired melanocytic nevus
70.2%
2ndNevus/mole
40.1%
Nevus
4.8%
Scar
7%
Papular urticaria
7.5%
Prurigo simplex
2.1%
Ephelides
15.24%
Pityriasis alba
18.3%
Dermatophytosis
11.4%
Pigmentary disorder
68.3%
Postinflammatory hypopigmentation
15.4%
3rdInsect bite reaction
28.0%
Cafe au lait
4.5%
Pyoderma
5.8%
Miliaria/heat rash
4.2%
Acne
1.3%
Atopic dermatitis
4.32%
Xerosis
11.8%
Non specific dermatoses
10.7%
Infection
5.6%
Xerosis
6.6%
4thAcanthosis nigricans
20.0%
Acne
1.6%
Miliaria/heat rash
5.2%
Eczema
4%
Pyoderma
1.3%
Verruca vulgaris
2.78%
Seborrhoeic dermatitis
6.7%
Pityriasis vesicolor
8.6%
Adnexal disorders
4.8%
Pityriasis alba
5.5%
5thAcne
13.7%
Mongolian spot
1.1%
Acne
4.7%
Prurigo simplex
3.7%
Eczema
0.8%
Keloid
0.33%
Wart
4.1%
Non specific ulcer
5%
Hypersensitivity diseases
14%
Livedo reticularis
5%
6thPityriasis alba
12.9%
Fungal infection
0.9%
Nevus and Prurigo simplex
3.7%
Other tinea
2.6%
Verrucae
0.4%
Tinea nigra, tinea versicolor, vitiligo
0.09%
Photosensitivity
4%
Pyoderma
4%
Genodermatoses
0.3%
Keratosis pilaris
4.8%
RemarksSchool and community basedSchool-based studySchool-based studySchool-based studyCommunity-based study (campaign field visit)School-based studySchool-based studySchool-based study
References Our study Fung and Lo5
1996–1997
Hogewoning et al.11
2004–2007
Chen et al.6
2007
Yamamah et al.10
2008–2009
Komba and Mgonda9
2010
El-Khateeb et al.8
2011–2012
Uludağ et al.7
2016
2007 2005 2007
City/countryThailandHong KongGhanaGabonRwandaMagong, Penghu/TaiwanSouth Sinai/EgyptDar es Salaam/TanzaniaDamietta/EgyptTurkey
Numbern = 556n = 559n = 1,394n = 454n= 2,528n = 3,237n = 2,194n = 420n = 6,162n = 1,386
Mean age (year)
(range)
9.3
(5–14)

(6–12.5)

(4–20)

(4–20)

(4–16)

(6–11)

(≤18)
11.4
(6–19)

(6–12)
7.31 ± 1.24
(5–14)
Rank 1stPIH
58.3%
Atopic eczema/eczema
7.6%
Tinea capitis
8.7%
Tinea capitis
23.1%
Tinea capitis
20.6%
Acne
17.3%
Pediculosis
37.6%
Acne
36.4%
Benign neoplasm
87%
Acquired melanocytic nevus
70.2%
2ndNevus/mole
40.1%
Nevus
4.8%
Scar
7%
Papular urticaria
7.5%
Prurigo simplex
2.1%
Ephelides
15.24%
Pityriasis alba
18.3%
Dermatophytosis
11.4%
Pigmentary disorder
68.3%
Postinflammatory hypopigmentation
15.4%
3rdInsect bite reaction
28.0%
Cafe au lait
4.5%
Pyoderma
5.8%
Miliaria/heat rash
4.2%
Acne
1.3%
Atopic dermatitis
4.32%
Xerosis
11.8%
Non specific dermatoses
10.7%
Infection
5.6%
Xerosis
6.6%
4thAcanthosis nigricans
20.0%
Acne
1.6%
Miliaria/heat rash
5.2%
Eczema
4%
Pyoderma
1.3%
Verruca vulgaris
2.78%
Seborrhoeic dermatitis
6.7%
Pityriasis vesicolor
8.6%
Adnexal disorders
4.8%
Pityriasis alba
5.5%
5thAcne
13.7%
Mongolian spot
1.1%
Acne
4.7%
Prurigo simplex
3.7%
Eczema
0.8%
Keloid
0.33%
Wart
4.1%
Non specific ulcer
5%
Hypersensitivity diseases
14%
Livedo reticularis
5%
6thPityriasis alba
12.9%
Fungal infection
0.9%
Nevus and Prurigo simplex
3.7%
Other tinea
2.6%
Verrucae
0.4%
Tinea nigra, tinea versicolor, vitiligo
0.09%
Photosensitivity
4%
Pyoderma
4%
Genodermatoses
0.3%
Keratosis pilaris
4.8%
RemarksSchool and community basedSchool-based studySchool-based studySchool-based studyCommunity-based study (campaign field visit)School-based studySchool-based studySchool-based study
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close